ATE319441T1 - Topische zusammensetzung und methode zur behandlung von harninkontinenz - Google Patents
Topische zusammensetzung und methode zur behandlung von harninkontinenzInfo
- Publication number
- ATE319441T1 ATE319441T1 AT01270327T AT01270327T ATE319441T1 AT E319441 T1 ATE319441 T1 AT E319441T1 AT 01270327 T AT01270327 T AT 01270327T AT 01270327 T AT01270327 T AT 01270327T AT E319441 T1 ATE319441 T1 AT E319441T1
- Authority
- AT
- Austria
- Prior art keywords
- treating urinary
- urinary incontinence
- topical composition
- composition
- phenylephrine
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 2
- 206010046543 Urinary incontinence Diseases 0.000 title 1
- 230000000699 topical effect Effects 0.000 title 1
- 206010066218 Stress Urinary Incontinence Diseases 0.000 abstract 1
- 239000000048 adrenergic agonist Substances 0.000 abstract 1
- 239000006071 cream Substances 0.000 abstract 1
- SONNWYBIRXJNDC-VIFPVBQESA-N phenylephrine Chemical compound CNC[C@H](O)C1=CC=CC(O)=C1 SONNWYBIRXJNDC-VIFPVBQESA-N 0.000 abstract 1
- 229960001802 phenylephrine Drugs 0.000 abstract 1
- 238000011200 topical administration Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Urology & Nephrology (AREA)
- Emergency Medicine (AREA)
- Gynecology & Obstetrics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Reproductive Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0030580.5A GB0030580D0 (en) | 2000-12-15 | 2000-12-15 | Composition and method |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE319441T1 true ATE319441T1 (de) | 2006-03-15 |
Family
ID=9905129
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01270327T ATE319441T1 (de) | 2000-12-15 | 2001-12-17 | Topische zusammensetzung und methode zur behandlung von harninkontinenz |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US20040044082A1 (de) |
| EP (1) | EP1347753B3 (de) |
| JP (1) | JP2004518646A (de) |
| KR (1) | KR100879656B1 (de) |
| AT (1) | ATE319441T1 (de) |
| AU (2) | AU2222102A (de) |
| CA (1) | CA2431519C (de) |
| DE (1) | DE60117685T3 (de) |
| DK (1) | DK1347753T5 (de) |
| ES (1) | ES2260160T7 (de) |
| GB (1) | GB0030580D0 (de) |
| PT (1) | PT1347753E (de) |
| WO (1) | WO2002047676A1 (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5173190B2 (ja) | 2004-08-25 | 2013-03-27 | 武田薬品工業株式会社 | 腹圧性尿失禁の予防・治療剤及びそのスクリーニング方法 |
| US7745665B2 (en) | 2007-06-04 | 2010-06-29 | Auspex Pharmaceuticals, Inc. | Substituted phenethylamines |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19514579A1 (de) * | 1995-04-20 | 1996-10-24 | Boehringer Ingelheim Kg | Verwendung von alpha¶1¶¶L¶-Agonisten zur Behandlung der Harninkontinenz |
| US5610174A (en) * | 1995-06-02 | 1997-03-11 | Synaptic Pharmaceutical Corporation | Use of α1A -selective adrenoceptor agonists for the treatment of urinary incontinence |
| US5861431A (en) * | 1995-06-07 | 1999-01-19 | Iotek, Inc. | Incontinence treatment |
| US5789442A (en) * | 1996-01-18 | 1998-08-04 | Schering Aktiengesellschaft | Treatment of urinary incontinence with nitric oxide synthase substrates and/or nitric oxide donors alone or in combination with estrogen or progesterone and/or other agents |
| WO1998011888A1 (en) | 1996-09-19 | 1998-03-26 | American Home Products Corporation | Method of treating urinary incontinence |
| PT946155E (pt) * | 1996-12-23 | 2006-07-31 | Sla Pharma Ag | Composicao farmaceutica para tratar incontinencia fecal e prurido anal |
| US6323231B1 (en) * | 2000-02-17 | 2001-11-27 | Abbott Laboratories | Use of α1A adrenoceptor agonists with α1B and α1D antagonism for the treatment of stress urinary incontinence |
-
2000
- 2000-12-15 GB GBGB0030580.5A patent/GB0030580D0/en not_active Ceased
-
2001
- 2001-12-17 AT AT01270327T patent/ATE319441T1/de active
- 2001-12-17 EP EP01270327A patent/EP1347753B3/de not_active Expired - Lifetime
- 2001-12-17 KR KR1020037008000A patent/KR100879656B1/ko not_active Expired - Fee Related
- 2001-12-17 JP JP2002549249A patent/JP2004518646A/ja active Pending
- 2001-12-17 WO PCT/GB2001/005545 patent/WO2002047676A1/en not_active Ceased
- 2001-12-17 ES ES01270327T patent/ES2260160T7/es active Active
- 2001-12-17 DK DK01270327T patent/DK1347753T5/da active
- 2001-12-17 CA CA2431519A patent/CA2431519C/en not_active Expired - Fee Related
- 2001-12-17 DE DE60117685T patent/DE60117685T3/de not_active Expired - Lifetime
- 2001-12-17 AU AU2222102A patent/AU2222102A/xx active Pending
- 2001-12-17 PT PT01270327T patent/PT1347753E/pt unknown
- 2001-12-17 AU AU2002222221A patent/AU2002222221B2/en not_active Ceased
- 2001-12-17 US US10/450,435 patent/US20040044082A1/en not_active Abandoned
-
2010
- 2010-03-25 US US12/731,259 patent/US20100239670A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| PT1347753E (pt) | 2006-07-31 |
| EP1347753A1 (de) | 2003-10-01 |
| DK1347753T3 (da) | 2006-07-10 |
| ES2260160T3 (es) | 2006-11-01 |
| CA2431519C (en) | 2010-05-04 |
| DK1347753T5 (da) | 2010-01-11 |
| KR100879656B1 (ko) | 2009-01-20 |
| DE60117685T3 (de) | 2010-02-18 |
| ES2260160T7 (es) | 2010-03-31 |
| EP1347753B1 (de) | 2006-03-08 |
| CA2431519A1 (en) | 2002-06-20 |
| AU2002222221B2 (en) | 2006-11-30 |
| DE60117685T2 (de) | 2006-09-21 |
| JP2004518646A (ja) | 2004-06-24 |
| DE60117685D1 (de) | 2006-05-04 |
| KR20030069184A (ko) | 2003-08-25 |
| US20040044082A1 (en) | 2004-03-04 |
| GB0030580D0 (en) | 2001-01-31 |
| EP1347753B3 (de) | 2009-08-12 |
| US20100239670A1 (en) | 2010-09-23 |
| AU2222102A (en) | 2002-06-24 |
| WO2002047676A1 (en) | 2002-06-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UA81638C2 (ru) | Композиция метронидазола для местного применения для лечения заболеваний аноректального и перианального участков | |
| ATE312635T1 (de) | Ventilanordnung | |
| UA41989C2 (uk) | Фармацевтична композиція у вигляді гелю для лікування захворювань шкіри та спосіб лікування інфікованої шкіри | |
| BRPI9908182C1 (pt) | composições de proteína de matriz para cura de feridas | |
| ATE238783T1 (de) | Mikrobenbeständige und stabilisierte lösungen, die gamma-hydroxybuttersäuresalze zur behandlung von narkolepsie enthalten | |
| ATE267798T1 (de) | Kombinierte wirkstoffe als methode zur gezielten wirkstoff-freisetzung | |
| EA200001044A3 (ru) | Соединения для лечения женской сексуальной дисфункции | |
| KR960010010A (ko) | 신규생리활성물질 | |
| ATE451123T1 (de) | Vaginal verabreichbare zusammensetzung zur behandlung von uteriner dysrhythmie | |
| ATE267583T1 (de) | Arzneizubereitungen zur behandlung sexueller funktionsstörungen | |
| HUP0202776A2 (hu) | (+)-Tramadol, O-demetil-tramadol, (+)-O-demetil-tramadol, O-demetil-N-mono-demetil-tramadol, illetve (+)-O-demetil-N-mono-demetil-tramadol felhasználása vizeletinkontinencia kezelésére alkalmas gyógyszerkészítmény előállítására | |
| PL402550A1 (pl) | Dopochwowe kompozycje farmaceutyczne oraz zastosowanie zródla nadtlenku i bioadhezyjnego nosnika | |
| DE59600683D1 (de) | Verwendung von Trospiumchlorid zur Herstellung eines Arzneimittels zur Behandlung von Blasenkrankheiten | |
| ATE369348T1 (de) | Zyklisierte benzamid-neurokinin-antagonisten zur verwendung in therapie | |
| BR0201974A (pt) | Composição farmacêutica para tratamento de alterações do sono | |
| DE60026883D1 (de) | Methoden und zusammensetzungen zur behandlung von schmerzen | |
| ATE319441T1 (de) | Topische zusammensetzung und methode zur behandlung von harninkontinenz | |
| HUP0203050A2 (hu) | Endometriózis és meddőség kezelésére, valamint a termékenység fokozására alkalmas gyógyszerkészítmények | |
| CY1106227T1 (el) | Συνθεση για τη διευκολυνση του ανθρωπινου τοκετου | |
| DE50100833D1 (de) | Verwendung von 2-methyl-thiazolidin-2,4-dicarbonsäure und / oder ihrer physiologisch verträglichen salze zur herstellung eines medikaments zur behandlung von krebserkrankungen | |
| ATE268173T1 (de) | Methoden zur behandlung von neurombedingten schmerzen | |
| US5576005A (en) | Effectiveness of wart removal by compositions including propolis | |
| ATE533480T1 (de) | Zusammensetzung zur behandlung von hämorrhoiden | |
| EA200501591A1 (ru) | Фармацевтическая комбинация для лечения мышечной спастичности и/или боли | |
| UA31728A (uk) | Препарат "імосдиніт-паста" для профілактики та лікування анаеробної інфекції та спосіб його одержання |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1347753 Country of ref document: EP |
|
| UEP | Publication of translation of european patent specification |
Ref document number: 1347753 Country of ref document: EP |